STS-135Also known as 5F-APICA
A fluorinated analogue of APICA, a CB1 and CB2 agonist of the adamantylated indole-3-carboxamide family.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₄H₃₁FN₂O
CAS 1354631-26-7
- Family
- Synthetic CB receptor agonistNew psychoactive substance
- Molar mass
- 382.50 g/mol
Updated on
In plain terms
STS-135 is a synthetic cannabinoid made in a laboratory, marketed as a legal alternative to marijuana. It acts on the same receptors as THC and binds very strongly to them in laboratory assays. It is classified as a narcotic in France.
Receptors and activity
Target network
- Activates
The lower the cited value, the closer the target sits to STS-135: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of STS-135.
CB1CB1 found in 7 regions of the body
- Basal gangliadenseMost dense in basal ganglia outflow nuclei1
- CerebellumdenseVery dense in the cerebellum1
- HippocampusdenseVery high concentrations in the hippocampus2
- AmygdaladenseHigh concentrations in the amygdala2
- CortexpresentPresent throughout the neocortex2
- Adipose tissuepresentExpressed in adipose tissue3
- GutpresentColonic epithelium, smooth muscle and plexus4
Map sources
- Herkenham M et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A, 1990 (new tab)
- Glass M et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 1997 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Wright K et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005 (new tab)
Cited values
- CB1AgonistKi = 2.5 nM · human77 out of 100
Hess et al. 2016, Forensic Toxicol (new tab) · competitive [3H]CP55,940 binding, CHO cell membranes
- CB2AgonistKi = 0.8 nM · human85 out of 100
Hess et al. 2016, Forensic Toxicol (new tab) · competitive [3H]CP55,940 binding, CHO cell membranes
Pharmacology
STS-135 is a synthetic cannabinoid of the adamantyl-headed indole-3-carboxamide family, the terminally fluorinated analogue of APICA (SDB-001). Hess et al. (2016) measure on human receptors Ki values of 2.51 nM at CB1 and 0.794 nM at CB2. In the series of Banister et al. (2015), which compares four synthetic cannabinoids with their fluorinated analogues (JWH-018/AM-2201, UR-144/XLR-11, PB-22/5F-PB-22, APICA/STS-135), all eight compounds induce a dose-dependent hypothermia and bradycardia in rats between 0.3 and 10 mg/kg; ranked by the magnitude and duration of hypothermia, APICA, STS-135 and XLR-11 share the same rank, behind PB-22, 5F-PB-22 and JWH-018. Jones et al. (2020) described its hepatic metabolism: 29 metabolites in hepatocytes, CYP3A4 as the main oxidative enzyme, and CYP2J2, expressed in cardiovascular tissues, forming the monohydroxylated metabolite with a Km of 11.4 µmol/L. The metabolites of APICA and ADB-PINACA lacking a carboxylic acid function retain agonist activity (Longworth et al. 2017). No human dose is characterised.
Key sources.
- Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol. 2016;34:329-343 (new tab)PMID 27429655
- Banister SD, Stuart J, Kevin RC et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 2015;6(8):1445-1458 (new tab)PMID 25921407
- Longworth M, Connor M, Banister SD, Kassiou M. Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA. ACS Chem Neurosci. 2017;8(8):1673-1680 (new tab)PMID 28574245
- Jones S, Yarbrough AL, Fantegrossi WE, Prather PL, Bush JM, Radominska-Pandya A, Fujiwara R. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacol Res Perspect. 2020;8(1):e00561 (new tab)PMID 32003945
- Council Framework Decision 2004/757/JHA, consolidated version of 12.01.2026 (annex: substances subject to Union control) (new tab)
History
- Source
- A wholly synthetic molecule, absent from cannabis and from every living organism. It belongs to the « designer drugs » marketed as legal alternatives to marijuana and is described as a third-generation synthetic cannabinoid (Jones et al. 2020). None of this has anything to do with hemp or with cannabidiol products.
Origin
Laboratory synthesis
No biological pathway: the molecule is entirely synthetic and belongs to the chemical family of the adamantyl-headed indole-3-carboxamides.
Legal framework
- European Union
It does not appear in the annex to Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which names only five synthetic cannabinoid agonists: MDMB-CHMICA, ADB-CHMINACA, CUMYL-4CN-BINACA, MDMB-4en-PINACA and 4F-MDMB-BICA. Nor does it appear in annex III of the consolidated ANSM list (tables I and II of the 1971 Convention on Psychotropic Substances).
- France
A narcotic in France, listed by name: the consolidated ANSM list (updated 16 February 2026) cites in annex IV « STS-135 ou 5F-APICA ou N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide », within the family of indole-3-carboxamide derivatives, which covers molecules bearing, among others, an adamantyl substituent on the nitrogen of the carboxamide bridge; the same list cites APICA (SDB-001 ou 2NE1).
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Synthetic CB receptor agonist › New psychoactive substance
- Class
indole-3-carboxamide
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol. 2016;34:329-343 (new tab)PMID 27429655
- Banister SD, Stuart J, Kevin RC et al. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 2015;6(8):1445-1458 (new tab)PMID 25921407
- Longworth M, Connor M, Banister SD, Kassiou M. Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA. ACS Chem Neurosci. 2017;8(8):1673-1680 (new tab)PMID 28574245
- Jones S, Yarbrough AL, Fantegrossi WE, Prather PL, Bush JM, Radominska-Pandya A, Fujiwara R. Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacol Res Perspect. 2020;8(1):e00561 (new tab)PMID 32003945
- Council Framework Decision 2004/757/JHA, consolidated version of 12.01.2026 (annex: substances subject to Union control) (new tab)
Identifiers
Names
- Common name
- STS-135 (5F-APICA)
- IUPAC name
- N-(1-adamantyl)-1-(5-fluoropentyl)indole-3-carboxamide
- Other names
- STS-135 · 5F-APICA · ACBM-2201 · N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide
Identifiers
- Formula
- C₂₄H₃₁FN₂O
- CAS
- 1354631-26-7
- PubChem CID
- 57404059(new tab)
- ChEBI
- 186830(new tab)
- InChIKey
- COYHGVCHRRXECF-UHFFFAOYSA-N
- SMILES
- C1C2CC3CC1CC(C2)
(C3) NC(= O) C4= CN(C5= CC= CC= C54) CCCCCF
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.